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Abstract
Objective:  To  report  the  case  of  a  newborn  with  recurrent  episodes  of  apnea,  diagnosed  with
Congenital  Central  hypoventilation  syndrome  (CCHS)  associated  with  Hirschsprung’s  disease
(HD), conﬁguring  Haddad  syndrome.
Case  description: Third  child  born  at  full-term  to  a  non-consanguineous  couple  through  nor-
mal delivery  without  complications,  with  appropriate  weight  and  length  for  gestational  age.
Soon after  birth  he  started  to  show  bradypnea,  bradycardia  and  cyanosis,  being  submitted  to
tracheal intubation  and  started  empiric  antibiotic  therapy  for  suspected  early  neonatal  sepsis.
During hospitalization  in  the  NICU,  he  showed  difﬁculty  to  undergo  extubation  due  to  episodes
of desaturation  during  sleep  and  wakefulness.  He  had  recurrent  episodes  of  hypoglycemia,
hyperglycemia,  metabolic  acidosis,  abdominal  distension,  leukocytosis,  increase  in  C-reactive
protein levels,  with  negative  blood  cultures  and  suspected  inborn  error  of  metabolism.  At  2
months of  age  he  was  diagnosed  with  long-segment  Hirschsprung’s  disease  and  was  submitted
to segment  resection  and  colostomy  through  Hartmann’s  procedure.  A  genetic  research  was
performed  by  polymerase  chain  reaction  for  CCHS  screening,  which  showed  the  mutated  alleleg  the  diagnosis.of PHOX2B  gene,  conﬁrmin
Comments:  This  is  a  rare  genetic,  autosomal  dominant  disease,  caused  by  mutation  in  PHOX2B
gene, located  in  chromosome  band  4p12,  which  results  in  autonomic  nervous  system  dysfunc-
tion. CCHS  can  also  occur  with  Hirschsprung’s  disease  and  tumors  derived  from  the  neural  crest.
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There  is  a  correlation  between  phenotype  and  genotype,  as  well  as  high  intrafamilial  phenotypic
variability.  In  the  neonatal  period  it  can  simulate  cases  of  sepsis  and  inborn  errors  of  metabolism.
© 2016  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY  license  (http://creativecommons.org/licenses/by/4.0/).
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Síndrome  de  hipoventilac¸ão central  congênita  associada  à  doenc¸a de  Hirschsprung:
relato  de  caso  e  revisão  de  literatura
Resumo
Objetivo:  Relatar  caso  de  neonato  com  episódios  de  apneias  recorrentes,  diagnosticado  com
síndrome  de  hipoventilac¸ão  central  congênita  (SHCC)  associada  à  doenc¸a  de  Hirschsprung  (DH),
o que  conﬁgurou  síndrome  de  Haddad.
Descric¸ão do  caso: Terceiro  ﬁlho  de  casal  não  consanguíneo,  nascido  a  termo,  parto  normal  sem
intercorrências,  peso  e  comprimento  adequados  para  idade  gestacional.  Logo  após  o  nascimento
apresentou  bradipneia,  bradicardia  e  cianose,  foi  submetido  à  intubac¸ão  orotraqueal  e  iniciada
antibioticoterapia  empírica  devido  à  suspeita  de  sepse  neonatal  precoce.  Durante  internac¸ão
em UTI  neonatal  evoluiu  com  diﬁculdade  de  extubac¸ão  devido  a  episódios  de  dessaturac¸ão
durante sono  e  vigília.  Apresentou  quadros  recorrentes  de  hipoglicemia,  hiperglicemia,  acidose
metabólica,  distensão  abdominal,  leucocitose,  aumento  de  proteína  C  reativa,  com  hemo-
culturas negativas  e  suspeita  de  erro  inato  do  metabolismo.  Aos  dois  meses  foi  diagnosticada
doenc¸a de  Hirschsprung  de  segmento  longo,  foi  submetido  à  ressecc¸ão  do  segmento  e  colosto-
mia à  Hartmann.  Feita  pesquisa  genética  por  reac¸ão  em  cadeia  da  polimerase  para  pesquisa  de
SHCC, que  evidenciou  alelo  mutado  do  gene  PHOX2B  e  conﬁrmou  o  diagnóstico.
Comentários:  Trata-se  de  doenc¸a  genética  rara,  de  heranc¸a  autossômica  dominante,  cau-
sada por  mutac¸ão  no  gene  PHOX2B, localizado  na  banda  cromossômica  4p12,  que  resulta
em disfunc¸ão  do  sistema  nervoso  autônomo.  A  SHCC  também  pode  cursar  com  doenc¸a  de
Hirschsprung  e  tumores  derivados  da  crista  neural.  Há  correlac¸ão  entre  fenótipo  e  genótipo,
além de  grande  variabilidade  fenotípica  intrafamiliar.  No  período  neonatal  pode  simular  quadros
de sepse  e  erros  inatos  do  metabolismo.
© 2016  Sociedade  de  Pediatria  de  Sa˜o  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY  (http://creativecommons.org/licenses/by/4.0/).
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CIntroduction
Congenital  central  hypoventilation  syndrome  (CCHS)  was
ﬁrst  described  by  Robert  Mellins  et  al.  in  1970.1 It  is  charac-
terized  by  central  apnea  crises  due  to  autonomic  nervous
system  dysfunction.2--5 Central  nervous  system  malforma-
tions,  as  well  as  lung  and  heart  disease,  should  be  ruled
out.  Hypoventilation  is  accentuated  during  sleep,  particu-
larly  in  the  non-REM  phase,  in  which  the  autonomic  control
of  breathing  predominates.6 For  this  reason  it  was  called
Ondine’s  curse  syndrome,  based  on  the  Norse  myth  of  Ondine
(1811)  by  Friedrich  La  Motte  Fouque,  which  tells  the  story
of  a  nymph  who  gives  up  immortality  to  live  a  human  love;
however,  when  she  is  betrayed,  she  curses  her  faithless  lover
to  forget  to  breathe  while  sleeping.7
In  1978,  Gabriel  Haddad  was  the  ﬁrst  author  to
describe  the  association  between  CCHS,  Hirschsprung’s
disease  and  tumors  derived  from  the  neural  crest,  in
addition  to  hypothesize  the  familial  character  of  the
disease.8 Approximately  15--20%  of  cases  of  CCHS  have
Hirschsprung’s  disease;  short  segment  involvement  (rec-
tosigmoid)  is  more  common,  but  long-segment  aganglionosis
4,9--11is  also  described. Tumors  derived  from  the  neural  crest
(neuroblastoma,  ganglioneuroma,  ganglioneuroblastoma)
occur  in  5--10%  of  cases,  especially  in  the  ﬁrst  two  years
of  life.12
(
a
gInitially  only  cases  of  severely  affected  newborns  were
eported  in  the  scientiﬁc  literature.  However,  from  1992
n,  cohort  studies  started  to  be  published,  which  broad-
ned  the  scope  of  the  syndrome  through  new  evidence  such
s  clinical  variants  of  later  onset  and  autonomic  nervous
ystem  involvement  in  other  organs,  which  expands  the
ossibilities  of  associated  clinical  manifestations  (cardiac
rrhythmias,  orthostatic  hypotension,  abnormal  pupillary
eﬂex,  esophageal  dysmotility,  diaphoresis,  decreased  heart
ate  variability,  chronic  constipation,  excessive  drowsiness
fter  use  of  sedatives  and  antihistamines).  Conﬁrmation  of
amilial  recurrence  emphasized  the  genetic  component  and
he  broad  phenotypic  spectrum.3,9--11,13--17
In  2003,  PHOX2B  gene  mutations  were  identiﬁed  as
esponsible  for  CCHS.  The  PHOX2B  gene  (paired-like  home-
box  gene),  located  on  chromosome  4p12,  encodes  a
ranscription  factor  responsible  for  the  regulation  of  genes
nvolved  in  the  development  of  the  autonomic  nervous
ystem.15 The  most  frequently  found  mutation  is  a  polyala-
ine  expansion  in  exon  3.  More  than  90%  of  affected
ndividuals  are  heterozygous  for  this  mutation.  The  normal
enotype  has  a  sequence  of  20  alanines  (20/20  genotype).
CHS  occurs  from  four  extra  alanines  in  one  of  the  alleles
20/24  genotype).  There  is  a  correlation  between  genotype
nd  phenotype,  i.e.,  the  higher  the  number  of  alanines,  the
reater  the  severity  of  clinical  ﬁndings.  The  presence  of  a
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utation  due  to  polyalanine  expansion  has  been  demon-
trated  by  molecular  genetic  testing  by  polymerase  chain
eaction.  Other  types  of  mutations  (missense,  frameshift)
ay  occur  and  are  demonstrated  by  gene  sequencing.4,11,16
The  central  breathing  control  depends  on  chemore-
eptors  expressed  in  specialized  neurons  located  in  the
etrotrapezoid  nucleus  in  the  brainstem  bulbar  region,
ensitive  to  carbon  dioxide  levels  in  Cerebrospinal  Fluid
CSF).2 They  are  integrated  into  the  neuronal  circuitry
hat  stimulates  the  phrenic  nerve  and,  consequently,  pro-
otes  diaphragm  movement  and  controls  ventilation  in
rder  to  maintain  homeostasis.  Retrotrapezoid  nucleus  neu-
ons  (RTNN)  express  the  PHOX2B  gene.  Mice  mutated  for  the
ene,  with  an  increase  of  seven  alanines,  show  85%  reduction
f  RTNN  and  can  survive  only  on  artiﬁcial  ventilation.18
Most  of  the  mutations  responsible  for  CCHS  are  de
ovo  mutations.  Approximately  10--25%  of  parents  are
symptomatic  carriers,  responsible  for  transmission  to  their
ffspring.15,16,19,20 Four  possibilities  are  described  for  asymp-
omatic  carriers:  presence  of  minor  polyalanine  expansion
up  to  three,  i.e.,  20/23  genotype),  20/24  or  20/25  geno-
ypes  with  incomplete  penetrance,  somatic  or  germinal
osaicism.11,15,16,19--21 A  risk  of  recurrence  of  up  to  50%
s  estimated.20 Recently  published  studies  show  extreme
ntrafamilial  phenotypic  variability,  from  the  elderly  indi-
idual  with  sleep  apnea,  chronic  constipation  and  lack  of
upillary  response  to  atropine,  to  the  neonate  with  CCHS
hat  depends  on  continuous  ventilatory  support.4,5,17,21,22
Thus,  the  aim  of  this  study  was  to  report  the  case  of  a
eonate  with  recurrent  apnea  episodes,  diagnosed  with  con-
enital  central  hypoventilation  syndrome  (CCHS)  associated
ith  Hirschsprung’s  disease,  conﬁguring  Haddad  syndrome.
ase description
ale  neonate,  born  at  term  to  non-consanguineous  par-
nts  (gestational  age  of  39  weeks  and  six  days)  through
aginal  delivery  without  complications,  classiﬁed  as  appro-
riate  for  gestational  age  (birth  weight  3390  g),  had  an  Apgar
core  of  8  in  the  1st  minute  and  9  in  the  5th  minute.  The
other  was  multiparous,  with  6  pregnancies  and  no  miscar-
iages,  aged  34  years;  the  pregnancy  was  uneventful.  The
ewborn  presented,  in  the  ﬁrst  hour  of  life,  with  bradyp-
ea,  bradycardia  and  cyanosis,  underwent  endotracheal
ntubation  and  antibiotics  for  suspected  early  neonatal  sep-
is.  The  echocardiography  showed  a  patent  foramen  ovale
ithout  hemodynamic  repercussions.  The  transfontanellar
ltrasonography  showed  no  abnormalities  suggestive  of  cen-
ral  nervous  system  malformations.  The  patient  had  delayed
econium  elimination,  on  the  4th  day  of  life  and  only  after
ectal  stimulation.  He  was  assessed  by  the  staff  of  pediatric
urgery,  which  identiﬁed  a  circular  stenosis  at  3.5  cm  of  the
ectum  through  digital  rectal  examination.
During  hospitalization  in  the  Neonatal  ICU,  in  the  ﬁrst
onth  of  life,  the  patient  had  difﬁculty  to  undergo  extuba-
ion.  Several  attempts  were  made  to  withdraw  mechanical
entilation  with  the  use  of  noninvasive  positive  pressure  ven-
ilation,  but  he  persisted  with  desaturation  episodes  during
leep  and  wakefulness.  Additionally,  there  were  recurrent
pisodes  of  metabolic  acidosis  and  three  episodes  of  respi-
atory  acidosis  during  ambient  air  maintenance  attempts.
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e  also  developed  hypoglycemic  episodes  alternating  with
yperglycemia,  recurrent  abdominal  distention,  leukocyto-
is  and  ﬂuctuating  increased  C-reactive  protein  levels  with
egative  blood  cultures.  Inborn  errors  of  metabolism  were
uspected.  The  best  option  to  offer  nutrition  was  through
ontinuous  gavage,  as  had  episodes  of  hypoglycemia  approx-
mately  one  hour  after  feeding.  If  the  glucose  infusion  rate
as  increased,  he  soon  showed  hyperglycemia.
There  was  a  family  history  of  a  brother  with  a  similar
eonatal  picture,  who  died  at  10  months  from  respira-
ory  complications,  with  an  undeﬁned  etiological  diagnosis,
ut  managed  as  a  carrier  of  organic  acidemia  (3-hydroxy-
-methylglutaryl-CoA  lyase  deﬁciency).  Thus,  tests  were
erformed  to  screen  for  inborn  errors  of  metabolism
expanded  neonatal  screening  test  and  research  of  organic
cids  in  the  urine)  and  a  leucine,  isoleucine  and  valine-free
ormula  was  initiated  empirically,  associated  with  the  use
f  high-dose  vitamins  t  (biotin,  riboﬂavin  and  L-carnitine).
here  was  no  clinical  improvement  after  the  institution  of
ietary  therapy  and  megavitamin.  The  newborn  screening
est  with  mass  spectrometry  and  research  of  urinary  organic
cids  were  normal.
At  two  months,  he  underwent  a  barium  enema,  which
howed  cone-shaped  transition  zone  at  the  splenic  ﬂex-
re  and  dilatation  upstream  and  Hirschsprung’s  disease
as  diagnosed.  He  underwent  intestinal  biopsy,  affected
egment  resection  and  Hartmann’s  colostomy.  Anato-
opathological  examination  showed  the  presence  of  a  nerve
lexus,  but  absence  of  ganglion  cells  in  the  rectum,  sigmoid,
ransition  zone  and  descending  colon;  nerve  plexus  with  gan-
lion  cells  was  present  only  in  the  transverse  and  ascending
olon.
Given  the  suspicion  of  congenital  central  hypoventila-
ion  syndrome  (CCHS)  associated  with  Hirschsprung’s  disease
nd  after  ruling  out  the  hypothesis  of  inborn  error  of
etabolism,  genetic  testing  was  performed  using  the  molec-
lar  technique  of  polymerase  chain  reaction  to  screen  for
CHS.
iscussion
ongenital  central  hypoventilation  syndrome  (CCHS)  is  a
are,  but  probably  underdiagnosed  disorder.  In  1999,  there
ere  approximately  160--180  known  cases  worldwide.5 The
rench  registry,  published  in  2005,  estimated  an  incidence
f  1:200,000  live  births  in  France.10 In  2009,  there  were
000  cases  conﬁrmed  by  molecular  studies.3 In  Brazil,  case
eports  of  isolated  were  published.7,22 This  case  report  aims
o  alert  health  professionals  about  the  existence  of  the  syn-
rome,  as  well  as  potential  confounders.
It  was  possible  to  make  the  diagnosis  of  CCHS  due
o  a  constellation  of  factors:  the  possibility  of  excluding
rganic  acidemia;  the  previous  experience  of  members  of
he  multidisciplinary  neonatal  ICU  team  who  hypothesized
he  presence  of  CCHS  and  persisted  in  their  investigation;
he  ﬁnding  of  Hirschsprung’s  disease  (HD)  during  evolution;
nd  access  to  genetic  testing.  The  patient’s  brother,  also
ossibly  affected  by  the  syndrome,  did  not  achieve  diagnos-
ic  clariﬁcation  in  life.  The  doubt  between  the  diagnosis  of
rganic  acidemia  and  CCHS  persisted  during  his  10  months
f  life,  mainly  because  the  excretion  of  organic  acids  in
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tumor risk in congenital central hypoventilation syndrome. Am
J Hum Genet. 2005;76:421--6.Congenital  central  hypoventilation  syndrome  associated  wit
urine  was  demonstrated  and  there  was  no  access  to  genetic
testing  at  the  time.  However,  after  reviewing  the  case,  it
is  believed  that  the  increase  in  acid  metabolite  excretion
was  related  to  the  patient’s  critical  condition  and  hypoxia.23
Another  interesting  fact  in  the  brother’s  history  was  the
report  of  hypoglycemic  episodes,  which  were  also  observed
in  the  newborn  described  herein,  alternating  with  episodes
of  hyperglycemia.  The  oscillations  in  glycemia  were  initially
attributed  to  the  presumed  inborn  error  of  metabolism  or
the  adverse  effects  of  the  speciﬁc  diet.  However,  there  are
studies  showing  liability  to  maintain  normal  blood  glucose
in  patients  with  CCHS.  Different  mechanisms  are  postulated
for  the  ﬁnding  and,  among  them,  hyperinsulinism.24,25
The  presence  of  a  mutated  allele  in  the  PHOX2B  gene  was
demonstrated  by  the  molecular  technique  of  polymerase
chain  reaction,  but  the  technique  used  does  not  quantify
the  number  of  polyalanine  expansions,  as  it  only  identiﬁes
the  presence  of  above  than  normal  expansions.  However,  it
seems  to  be  the  most  severe  phenotype,  due  to  the  onset
of  symptoms  in  the  neonatal  period  and  the  association
with  Hirschsprung’s  disease.  Approximately  87--100%  of  the
cases  caused  by  non-polyalanine  repeat  expansion  mutations
(NPARM)  have  Hirschsprung’s  disease.4 In  cases  of  mutation
due  to  polyalanine  repeat  expansion,  a  lower  occurrence  of
association  with  Hirschsprung’s  disease  is  expected,  of  about
20%.4 Neural  crest  cell-derived  tumors  are  found  in  50%  of
cases  with  NPARM  mutations  and  in  only  1%  of  those  with
mutations  due  to  polyalanine  repeat  expansion.3,4,11
The  parents  have  not  been  submitted  to  mutation
screening,  but  considering  the  history  of  familial  recur-
rence,  it  is  likely  that  one  of  them  is  a  carrier.  There
are  no  reports  of  other  cases  in  the  family.  The  mother
has  postural  hypotension  and  chronic  constipation,  which
may  represent  mild  symptoms  of  autonomic  nervous  system
dysfunction.3,13,14 Approximately  10--25%  of  cases  of  CCHS
are  due  to  inherited  mutation,  transmitted  by  asymptomatic
carriers.20,21
Central  hypoventilation  is  the  cardinal  sign  of  CCHS
and  the  characteristic  with  the  highest  morbimortality.4
The  genotype  is  associated  with  the  need  for  mechani-
cal  ventilation.  Carriers  of  the  20/25  genotype  have  later
clinical  presentation  and  are  rarely  depend  on  ventila-
tory  support.4 On  the  other  hand,  carriers  of  the  genotype
20/27  to  20/33  usually  depend  on  continuous  ventilatory
support.4 Mortality  is  mainly  due  to  sudden  death  or  pul-
monary  complications  secondary  to  prolonged  mechanical
ventilation.  Many  develop  pulmonary  hypertension,  cor  pul-
monale  and  hypoxic-ischemic  lesions,  caused  by  inadequate
ventilatory  support.4,9,10,13
The  diagnosis  and  management  of  these  patients  are
quite  challenging.  The  rarity  of  the  disease,  the  broad  dif-
ferential  diagnosis  (malformations,  sepsis,  inborn  errors  of
metabolism),  restricted  access  to  speciﬁc  genetic  tests,
the  need  for  ventilatory  support  at  birth  and  follow-up
with  a  multidisciplinary  team  (pediatricians,  intensivists,
pediatric  surgeons,  geneticists,  physical  therapists,  nurses,
nutritionists)  are  the  basis  of  the  previous  statement.  The
survival  and  quality  of  life  can  be  improved  through  the
planning  of  early  tracheostomy  and  gastrostomy,  efﬁcient
deinstitutionalization  process,  access  to  home  care  pro-
grams  and  even  the  possibility  of  diaphragmatic  pacemaker
implantation.4,9
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